CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy 10% owner bought 343,631 shares at $2.16 ($742,243)
- 4 Open-market buy Director bought 25,000 shares at $2.30 ($57,500)
- 4 Open-market buy Director bought 60,000 shares at $2.34 ($140,568)
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 17 · 325 filings